In the last trading session, 1.04 million Lineage Cell Therapeutics Inc (AMEX:LCTX) shares changed hands as the company’s beta touched 1.33. With the company’s per share price at $1.30 changed hands at -$0.11 or -7.80% during last session, the market valuation stood at $245.09M. LCTX’s last price was a discount, traded about -23.85% off its 52-week high of $1.61. The share price had its 52-week low at $0.84, which suggests the last value was 35.38% up since then. When we look at Lineage Cell Therapeutics Inc’s average trading volume, we note the 3-month average coming to 908.85K.

Lineage Cell Therapeutics Inc (AMEX:LCTX) trade information

Instantly LCTX was in red as seen at the end of in last trading. With action -7.14%, the performance over the past five days has been red. The drop to weekly highs of 1.4700 subtracted -7.80% to the stock’s daily price. The company’s shares are showing year-to-date upside of 19.27%, with the 5-day performance at -7.14% in the red. However, in the 30-day time frame, Lineage Cell Therapeutics Inc (AMEX:LCTX) is 7.44% up.

Lineage Cell Therapeutics Inc (LCTX) estimates and forecasts

Data shows that the Lineage Cell Therapeutics Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 1.56% over the past 6 months, a -33.33% in annual growth rate that is considerably lower than the industry average of 13.00%. Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 19.25%. The 2024 estimates are for Lineage Cell Therapeutics Inc earnings to increase by 5.56%.